Auna (AUNA) Competitors

$4.79 -0.22 (-4.31%)

Closing price 05/15/2026 03:59 PM Eastern

Extended Trading

$4.86 +0.07 (+1.38%)

As of 05/15/2026 06:32 PM Eastern

AUNA vs. VRDN, AVAH, ARDT, TDOC, and FTRE

Should you buy Auna stock or one of its competitors? MarketBeat compares Auna with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Auna include Viridian Therapeutics (VRDN), Aveanna Healthcare (AVAH), Ardent Health (ARDT), Teladoc Health (TDOC), and Fortrea (FTRE). These companies are all part of the "healthcare" industry.

How does Auna compare to Viridian Therapeutics?

Auna (NYSE:AUNA) and Viridian Therapeutics (NASDAQ:VRDN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

Auna has higher revenue and earnings than Viridian Therapeutics. Viridian Therapeutics is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Auna	$1.23B	0.29	$27.39M	$0.36	13.32
Viridian Therapeutics	$70.85M	24.47	-$342.60M	-$3.32	N/A

Auna currently has a consensus price target of $7.30, suggesting a potential upside of 52.27%. Viridian Therapeutics has a consensus price target of $36.14, suggesting a potential upside of 114.88%. Given Viridian Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Viridian Therapeutics is more favorable than Auna.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Viridian Therapeutics	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.79

Auna has a net margin of 2.13% compared to Viridian Therapeutics' net margin of -490.31%. Auna's return on equity of 19.23% beat Viridian Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Auna	2.13%	19.23%	4.70%
Viridian Therapeutics	-490.31%	-80.19%	-48.84%

Auna has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market. Comparatively, Viridian Therapeutics has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

In the previous week, Viridian Therapeutics had 6 more articles in the media than Auna. MarketBeat recorded 8 mentions for Viridian Therapeutics and 2 mentions for Auna. Viridian Therapeutics' average media sentiment score of 1.17 beat Auna's score of -0.07 indicating that Viridian Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Auna	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Viridian Therapeutics	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Auna beats Viridian Therapeutics on 9 of the 15 factors compared between the two stocks.

How does Auna compare to Aveanna Healthcare?

Auna (NYSE:AUNA) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

In the previous week, Aveanna Healthcare had 18 more articles in the media than Auna. MarketBeat recorded 20 mentions for Aveanna Healthcare and 2 mentions for Auna. Aveanna Healthcare's average media sentiment score of 0.87 beat Auna's score of -0.07 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Auna	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aveanna Healthcare	7 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Auna has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.93, indicating that its share price is 93% more volatile than the broader market.

Aveanna Healthcare has higher revenue and earnings than Auna. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Auna	$1.23B	0.29	$27.39M	$0.36	13.32
Aveanna Healthcare	$2.43B	0.69	$225.03M	$1.02	7.57

88.0% of Aveanna Healthcare shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Aveanna Healthcare has a net margin of 10.37% compared to Auna's net margin of 2.13%. Aveanna Healthcare's return on equity of 210.63% beat Auna's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Auna	2.13%	19.23%	4.70%
Aveanna Healthcare	10.37%	210.63%	7.22%

Auna currently has a consensus price target of $7.30, suggesting a potential upside of 52.27%. Aveanna Healthcare has a consensus price target of $10.44, suggesting a potential upside of 35.29%. Given Auna's higher possible upside, equities analysts clearly believe Auna is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Aveanna Healthcare	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.58

Summary

Aveanna Healthcare beats Auna on 14 of the 16 factors compared between the two stocks.

How does Auna compare to Ardent Health?

Auna (NYSE:AUNA) and Ardent Health (NYSE:ARDT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

In the previous week, Ardent Health had 3 more articles in the media than Auna. MarketBeat recorded 5 mentions for Ardent Health and 2 mentions for Auna. Ardent Health's average media sentiment score of 0.39 beat Auna's score of -0.07 indicating that Ardent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Auna	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ardent Health	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Auna has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market. Comparatively, Ardent Health has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

Ardent Health has higher revenue and earnings than Auna. Ardent Health is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Auna	$1.23B	0.29	$27.39M	$0.36	13.32
Ardent Health	$6.32B	0.23	$135.81M	$0.95	10.65

Auna has a net margin of 2.13% compared to Ardent Health's net margin of 2.09%. Auna's return on equity of 19.23% beat Ardent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Auna	2.13%	19.23%	4.70%
Ardent Health	2.09%	13.85%	4.48%

Auna presently has a consensus price target of $7.30, suggesting a potential upside of 52.27%. Ardent Health has a consensus price target of $14.21, suggesting a potential upside of 40.48%. Given Auna's stronger consensus rating and higher probable upside, research analysts clearly believe Auna is more favorable than Ardent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Summary

Auna beats Ardent Health on 9 of the 15 factors compared between the two stocks.

How does Auna compare to Teladoc Health?

Auna (NYSE:AUNA) and Teladoc Health (NYSE:TDOC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

In the previous week, Teladoc Health had 13 more articles in the media than Auna. MarketBeat recorded 15 mentions for Teladoc Health and 2 mentions for Auna. Teladoc Health's average media sentiment score of 0.51 beat Auna's score of -0.07 indicating that Teladoc Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Auna	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Teladoc Health	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Auna has a beta of 1.03, indicating that its stock price is 3% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.08, indicating that its stock price is 108% more volatile than the broader market.

Auna has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Auna	$1.23B	0.29	$27.39M	$0.36	13.32
Teladoc Health	$2.53B	0.45	-$200.32M	-$0.97	N/A

76.8% of Teladoc Health shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Auna has a net margin of 2.13% compared to Teladoc Health's net margin of -6.81%. Auna's return on equity of 19.23% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Auna	2.13%	19.23%	4.70%
Teladoc Health	-6.81%	-11.45%	-5.54%

Auna presently has a consensus price target of $7.30, suggesting a potential upside of 52.27%. Teladoc Health has a consensus price target of $7.53, suggesting a potential upside of 18.32%. Given Auna's stronger consensus rating and higher probable upside, research analysts clearly believe Auna is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Teladoc Health	1 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.22

Summary

Auna beats Teladoc Health on 9 of the 17 factors compared between the two stocks.

How does Auna compare to Fortrea?

Fortrea (NASDAQ:FTRE) and Auna (NYSE:AUNA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

Auna has a net margin of 2.13% compared to Fortrea's net margin of -16.50%. Auna's return on equity of 19.23% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Auna	2.13%	19.23%	4.70%

Fortrea has a beta of 1.92, suggesting that its share price is 92% more volatile than the broader market. Comparatively, Auna has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market.

Fortrea presently has a consensus price target of $17.25, suggesting a potential upside of 26.28%. Auna has a consensus price target of $7.30, suggesting a potential upside of 52.27%. Given Auna's stronger consensus rating and higher probable upside, analysts clearly believe Auna is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

Auna has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.47	-$986.20M	-$4.91	N/A
Auna	$1.23B	0.29	$27.39M	$0.36	13.32

In the previous week, Fortrea had 6 more articles in the media than Auna. MarketBeat recorded 8 mentions for Fortrea and 2 mentions for Auna. Fortrea's average media sentiment score of 0.77 beat Auna's score of -0.07 indicating that Fortrea is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Auna	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Auna beats Fortrea on 9 of the 15 factors compared between the two stocks.

Get Auna News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AUNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AUNA vs. The Competition

Export

Metric	Auna	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$370.80M	$8.29B	$6.43B	$22.98B
Dividend Yield	N/A	3.05%	2.80%	4.09%
P/E Ratio	13.32	21.86	20.38	29.75
Price / Sales	0.29	20.67	566.19	14.04
Price / Cash	2.56	80.56	43.04	25.31
Price / Book	0.72	5.45	9.87	4.60
Net Income	$27.39M	$183.43M	$3.57B	$1.07B
7 Day Performance	-4.84%	-1.16%	0.31%	-2.27%
1 Month Performance	-12.84%	0.47%	-1.27%	-0.37%
1 Year Performance	-31.07%	-0.37%	33.54%	21.80%

Auna Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AUNA Auna	4.2216 of 5 stars	$4.79 -4.3%	$7.30 +52.3%	-31.2%	$370.80M	$1.23B	13.32	15,254	Upcoming Earnings Analyst Downgrade
VRDN Viridian Therapeutics	3.8944 of 5 stars	$18.77 +33.5%	$37.07 +97.5%	+33.3%	$1.45B	$70.85M	N/A	50	Positive News Analyst Forecast Insider Trade High Trading Volume
AVAH Aveanna Healthcare	4.8465 of 5 stars	$6.47 -2.4%	$10.25 +58.4%	+28.7%	$1.44B	$2.43B	6.34	35,500	Trending News Earnings Report Analyst Upgrade Gap Up
ARDT Ardent Health	3.7802 of 5 stars	$10.13 +1.5%	$14.25 +40.7%	-33.7%	$1.43B	$6.32B	6.05	25,200	Analyst Upgrade
TDOC Teladoc Health	3.1693 of 5 stars	$6.68 +0.7%	$7.53 +12.8%	-12.6%	$1.20B	$2.53B	N/A	5,600	Trending News Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AUNA) was last updated on 5/16/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Auna (AUNA) Competitors

AUNA vs. VRDN, AVAH, ARDT, TDOC, and FTRE

How does Auna compare to Viridian Therapeutics?

Summary

How does Auna compare to Aveanna Healthcare?

Summary

How does Auna compare to Ardent Health?

Summary

How does Auna compare to Teladoc Health?

Summary

How does Auna compare to Fortrea?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AUNA vs. The Competition

Auna Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Auna (AUNA) Competitors

AUNA vs. VRDN, AVAH, ARDT, TDOC, and FTRE

How does Auna compare to Viridian Therapeutics?

Which has higher valuation & earnings, AUNA or VRDN?

Do analysts rate AUNA or VRDN?

Is AUNA or VRDN more profitable?

Which has more volatility & risk, AUNA or VRDN?

Does the media favor AUNA or VRDN?

Summary

How does Auna compare to Aveanna Healthcare?

Does the media favor AUNA or AVAH?

Which has more volatility and risk, AUNA or AVAH?

Which has higher valuation & earnings, AUNA or AVAH?

Do institutionals & insiders hold more shares of AUNA or AVAH?

Is AUNA or AVAH more profitable?

Do analysts rate AUNA or AVAH?

Summary

How does Auna compare to Ardent Health?

Does the media prefer AUNA or ARDT?

Which has more volatility & risk, AUNA or ARDT?

Which has stronger earnings & valuation, AUNA or ARDT?

Is AUNA or ARDT more profitable?

Do analysts rate AUNA or ARDT?

Summary

How does Auna compare to Teladoc Health?

Does the media refer more to AUNA or TDOC?

Which has more risk and volatility, AUNA or TDOC?

Which has stronger earnings & valuation, AUNA or TDOC?

Do institutionals & insiders hold more shares of AUNA or TDOC?

Is AUNA or TDOC more profitable?

Do analysts rate AUNA or TDOC?

Summary

How does Auna compare to Fortrea?

Is FTRE or AUNA more profitable?

Which has more risk and volatility, FTRE or AUNA?

Do analysts prefer FTRE or AUNA?

Which has preferable earnings & valuation, FTRE or AUNA?

Does the media prefer FTRE or AUNA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AUNA vs. The Competition

Auna Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools